Keyphrases
Direct Oral Anticoagulants
100%
Clinical Pharmacist
100%
Pharmacist-led
100%
Stewardship Program
100%
Drug-related Problems
54%
Potentially Inappropriate Medication
36%
Patient Characteristics
18%
Dosing Regimen
18%
Potentially Inappropriate
18%
Physician Acceptance
18%
Potentially Inappropriate Drugs
18%
Coagulation
9%
Pharmacology
9%
Life-threatening
9%
Hospitalization
9%
Patient Management
9%
Trial Registration
9%
Evenly Distributed
9%
Collaborative Projects
9%
Medical Practice
9%
Reduced Dose
9%
Attending Physicians
9%
Effective Method
9%
Drug Type
9%
Electronic Medical Records
9%
Dabigatran
9%
Apixaban
9%
Rivaroxaban
9%
Clinical Pharmacy
9%
Acceptance Rate
9%
Anticoagulation Management
9%
Management Options
9%
Safe Utilization
9%
Program Performance
9%
Level Monitoring
9%
Antiplatelet Agents
9%
Physician Response
9%
Consultation Rates
9%
Effective Utilization
9%
Pharmacist Consultation
9%
Pharmacy Team
9%
Additional Guidance
9%
Underdosing
9%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Direct Oral Anticoagulant
100%
Rivaroxaban
10%
Dabigatran
10%
Apixaban
10%
Antithrombocytic Agent
10%